POLISCOPE
Back to feed
Part ofhealth
S494FEDERALin_committee

National Plan for Epilepsy Act

February 10, 2025

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Feb 10, 2025

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

The bill mandates the creation of a national strategy to address the $54 billion annual cost of epilepsy and improve care for the nearly 3.5 million Americans living with the condition.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Individuals living with epilepsy

The bill aims to coordinate care and research that could impact diagnosis, treatment access, and quality of life.

Federal health agencies (NIH, FDA, CDC, etc.)

These agencies are required to participate in the Advisory Council and coordinate their epilepsy-related research and services.

Epilepsy caregivers

The bill includes caregivers in the Advisory Council and mandates that the national plan address their needs.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This bill proposes a new federal initiative to coordinate epilepsy research, diagnosis, and treatment across government agencies. It would establish an Advisory Council on Epilepsy Research, Care, and Services to provide recommendations and report on progress to Congress.

Key Facts

  • The Secretary of Health and Human Services must establish a 'National Plan for Epilepsy' to coordinate research, prevention, and treatment across all federal agencies.
  • An Advisory Council on Epilepsy Research, Care, and Services will be created, consisting of federal agency representatives and 13 non-federal experts (patients, caregivers, providers, and researchers).
  • The Advisory Council must meet at least quarterly and hold public meetings.
  • The Secretary must produce an annual progress assessment starting 2 years after enactment.
  • The Advisory Council must submit a report to Congress every 2 years, starting 18 months after enactment, evaluating federal efforts and recommending priority actions.
  • Epilepsy affects approximately 3,000,000 adults and 456,000 children in the U.S.
  • Annual healthcare costs associated with epilepsy exceed $54 billion.
  • 32% of adults with epilepsy are unable to work.
  • 53% of individuals with uncontrolled seizures live in households earning less than $25,000 per year.
  • Individuals with epilepsy have a 3-times higher risk of early death than the general population.

Frequently Asked Questions

What is the goal of the National Plan for Epilepsy?
The goal is to coordinate federal research, improve early diagnosis, enhance treatment, and reduce the physical, mental, and social impact of epilepsy on patients and caregivers.
Who will serve on the Advisory Council?
The council will include representatives from federal agencies like the NIH, FDA, and VA, along with 13 non-federal members including patients, caregivers, medical providers, and nonprofit representatives.
Will the public be able to participate?
Yes, the bill requires that all meetings of the Advisory Council be open to the public.

Why It Matters

The bill mandates the creation of a national strategy to address the $54 billion annual cost of epilepsy and improve care for the nearly 3.5 million Americans living with the condition.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Federal Coordination Focus

The bill shifts from fragmented agency research to a centralized 'National Plan' model, explicitly requiring inter-agency coordination between the NIH, FDA, CDC, and others.

Connected Entities

personMr. SchmittSenator who introduced the bill.Map →
personMr. BoozmanSenator who co-sponsored the bill.Map →
organizationCommittee on Health, Education, Labor, and PensionsSenate committee currently reviewing the bill.Map →
personMs. KlobucharSenator who co-sponsored the bill.Map →
personMs. HassanSenator who co-sponsored the bill.Map →

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record